Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Innovative Medicines Initiative: Calling for research on immunotherapies?

Date

29 Sep 2019

Session

Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Topics

Management of Systemic Therapy Toxicities;  Bioethical Principles and GCP;  Tumour Immunology;  Immunotherapy;  Translational Research;  Supportive Care and Symptom Management

Tumour Site

Presenters

Kjetil Tasken

Authors

K. Tasken

Author affiliations

  • Dept. Of Cancer Immunology, Oslo University Hospital - The Norwegian Radium Hospital, 0424 - Oslo/NO

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.